Pricing Log in Create free account
Reset Show charts
Market Cap

Your own ranges are part of Powerpack. Powerpack

Stock Price

Your own ranges are part of Powerpack. Powerpack

P/E ratio

Your own ranges are part of Powerpack. Powerpack

P/S ratio

Your own ranges are part of Powerpack. Powerpack

EV/EBITDA

Your own ranges are part of Powerpack. Powerpack

Free Cash Flow Yield

Your own ranges are part of Powerpack. Powerpack

Revenue Growth

Your own ranges are part of Powerpack. Powerpack

EPS Growth (diluted)

Your own ranges are part of Powerpack. Powerpack

Net Profit Margin

Your own ranges are part of Powerpack. Powerpack

ROE

Your own ranges are part of Powerpack. Powerpack

ROIC

Your own ranges are part of Powerpack. Powerpack

Debt/Equity

Your own ranges are part of Powerpack. Powerpack

Annual Dividend Yield

Your own ranges are part of Powerpack. Powerpack

Piotroski F-Score

Your own ranges are part of Powerpack. Powerpack

Revenue

Your own ranges are part of Powerpack. Powerpack

Free Cash Flow

Your own ranges are part of Powerpack. Powerpack

Sector
EPS (Diluted)

Your own ranges are part of Powerpack. Powerpack

TTM trailing twelve months Q latest quarter A latest fiscal year D daily, from the latest close

Showing the 10 largest of 149 matches.
1 filter active
Table Snapshots

  1. Abbott Laboratories

    ABT Healthcare · Medical Devices · US

    $113.42 −8.93% 1Y
    Low $81.97 High $132.03

    Abbott Laboratories is a healthcare-products company headquartered in North Chicago and led by Chief Executive Officer Robert Ford. It discovers, develops, manufactures and sells products across four businesses: Medical Devices, Diagnostic Products, Nutritional Products and Established Pharmaceutical Products.

    Market cap $196.6B
    Revenue growth (Q) +14.5%
    EPS growth (Q) −43.6%
    FCF growth (Q) +28.9%
    Revenue growth (next yr) +12.7%
    Net margin 9.75%
    ROE 0.00%
    P/E 42.3×
    Forward P/E 35.1×
    P/FCF 25.2×
    Dividend yield 2.22%
    Insider ownership 1.17%
    Insider buys / sells (12M) $4.4M $47.5M
    Reported FY2022 FY2023 FY2024 FY2025 TTM
    Revenue $43.7B $40.1B $42.0B $44.3B $48.2B
    EPS $3.91 $3.26 $7.64 $3.72 $2.68
    Free cash flow $7.8B $5.1B $6.4B $7.4B $7.8B
    Net debt $6.6B $7.4B $6.2B $4.0B $27.0B

  2. Medtronic PLC

    MDT Healthcare · Medical Devices · IE

    $104.51 +15.6% 1Y
    Low $73.31 High $106.33

    Medtronic is a healthcare technology company headquartered in Galway, Ireland. Founded in 1949, it develops, manufactures, distributes and sells device-based medical therapies and related services.

    Market cap $134.1B
    Revenue growth (Q) +13.7%
    EPS growth (Q) +40.7%
    FCF growth (Q) +120.9%
    Revenue growth (next yr) +7.17%
    Net margin 13.9%
    ROE 10.6%
    P/E 25.6×
    Forward P/E 20.8×
    P/FCF 21.8×
    Dividend yield 2.74%
    Insider ownership 0.00%
    Insider buys / sells (12M) — $14.7M
    Reported FY2023 FY2024 FY2025 FY2026 TTM
    Revenue $31.2B $32.4B $33.5B $36.4B $37.5B
    EPS $2.82 $2.76 $3.61 $3.73 $4.06
    Free cash flow $4.6B $5.2B $5.2B $5.4B $6.1B
    Net debt $16.4B $17.0B $19.6B $18.7B $19.3B

  3. Stryker Corporation

    SYK Healthcare · Medical Devices · US

    $333.88 −6.65% 1Y
    Low $267.00 High $389.33

    Stryker is a medical technology company that sells equipment, implants and other products used in hospitals and other healthcare facilities. Its businesses cover medical and surgical care, treatments for vascular and neurological conditions, and orthopaedics.

    Market cap $127.6B
    Revenue growth (Q) +7.64%
    EPS growth (Q) −11.7%
    FCF growth (Q) −19.4%
    Revenue growth (next yr) +6.77%
    Net margin 13.8%
    ROE 16.0%
    P/E 35.3×
    Forward P/E 24.6×
    P/FCF 28.9×
    Dividend yield 1.05%
    Insider ownership 6.25%
    Insider buys / sells (12M) — $401.5M
    Reported FY2022 FY2023 FY2024 FY2025 TTM
    Revenue $18.4B $20.5B $22.6B $25.1B $26.3B
    EPS $6.17 $8.25 $7.76 $8.40 $9.39
    Free cash flow $2.0B $3.1B $3.5B $4.3B $4.4B
    Net debt $11.1B $9.9B $9.1B $11.8B $11.7B

  4. Boston Scientific Corporation

    BSX Healthcare · Medical Devices · US

    $44.36 −55.2% 1Y
    Low $39.57 High $105.65

    Boston Scientific develops, manufactures and markets medical devices used by physicians and other medical professionals. Its products help diagnose and treat conditions affecting the heart and blood vessels, digestive and urinary systems, and nervous system, as well as some cancers.

    Market cap $64.7B
    Revenue growth (Q) +1.44%
    EPS growth (Q) −21.6%
    FCF growth (Q) −25.3%
    Revenue growth (next yr) +4.44%
    Net margin 16.6%
    ROE 14.2%
    P/E 18.7×
    Forward P/E 17.0×
    P/FCF 19.3×
    Dividend yield —
    Insider ownership 0.60%
    Insider buys / sells (12M) $10.0M $18.1M
    Reported FY2022 FY2023 FY2024 FY2025 TTM
    Revenue $12.7B $14.2B $16.7B $20.1B $21.1B
    EPS $0.45 $1.07 $1.25 $1.94 $2.36
    Free cash flow $950.0M $1.8B $2.6B $3.7B $3.3B
    Net debt $8.0B $8.2B $10.3B $9.5B $11.3B

  5. Edwards Lifesciences Corporation

    EW Healthcare · Medical Devices · US

    $100.35 +21.1% 1Y
    Low $74.66 High $104.17

    Edwards Lifesciences makes medical devices for structural heart disease, with a focus on repairing or replacing heart valves. A faulty valve can disrupt the heart’s function or blood flow.

    Market cap $58.1B
    Revenue growth (Q) +10.5%
    EPS growth (Q) +6.00%
    FCF growth (Q) −1.84%
    Revenue growth (next yr) +11.4%
    Net margin 15.3%
    ROE 9.65%
    P/E 56.7×
    Forward P/E 36.5×
    P/FCF 41.5×
    Dividend yield —
    Insider ownership 1.20%
    Insider buys / sells (12M) — $27.7M
    Reported FY2022 FY2023 FY2024 FY2025 TTM
    Revenue $4.5B $5.0B $5.4B $6.1B $6.7B
    EPS $2.44 $2.30 $6.97 $1.83 $1.77
    Free cash flow $953.4M $629.5M $259.9M $1.3B $1.4B
    Net debt −$619.0M −$1.0B −$3.4B −$3.6B $598.8M